IGHE and cancer: Binding of both Tras and Per IgE to SKBR3 cancer cells (HER2 3+) and RBL-SX38 cells transgenically expressing human FcεRI, confirmed the ability to engage via the Fab and Fc regions, respectively (figure 2C).